Hans Biomed (XKRX:042520) Ending Cash Position : ₩7,652 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Ending Cash Position?

Hans Biomed's Ending Cash Position for the quarter that ended in Mar. 2024 was ₩7,652 Mil.

Hans Biomed's quarterly Ending Cash Position increased from Sep. 2023 (₩6,132 Mil) to Dec. 2023 (₩6,760 Mil) and increased from Dec. 2023 (₩6,760 Mil) to Mar. 2024 (₩7,652 Mil).

Hans Biomed's annual Ending Cash Position increased from Sep. 2021 (₩7,051 Mil) to Sep. 2022 (₩7,524 Mil) but then declined from Sep. 2022 (₩7,524 Mil) to Sep. 2023 (₩6,132 Mil).

Hans Biomed Ending Cash Position Historical Data

The historical data trend for Hans Biomed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Ending Cash Position Chart

Hans Biomed Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Ending Cash Position

Get a 7-Day Free Trial

10,404.34

13,840.50

7,050.82

7,523.96

6,131.61

Hans Biomed Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															6,974.03	6,510.21	6,131.61	6,760.07	7,651.73

Hans Biomed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hans Biomed's Ending Cash Position for the fiscal year that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7523.956	+	-1392.349
	=	6,132

Hans Biomed's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	6760.067	+	891.664
	=	7,652

Hans Biomed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hans Biomed (XKRX:042520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

8th Floor SK Building 16-4, Sungsu 1 ga Dong, Sungdong-gu, Seoul, KOR

Website

http://www.hansbiomed.com

Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures artificial skin for a skin graft, various bones mainly for dental implants and joints and medical silicone.

Hans Biomed (XKRX:042520) Headlines

No Headlines